Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 17Multiple Myeloma 4Esophageal Neoplasms 4Barrett Esophagus 4Neoplasms, Plasma Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Advanced Malignant Neoplasm 3Adenocarcinoma Of Esophagus 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Secondary Malignant Neoplasm of Spine 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pediatric Cancer Patients 2Papillomavirus Infections 2Mouth Neoplasms 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Locally Advanced Malignant Neoplasm 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2

Interventions

Fentanyl 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Intrathecal Dexmedetomidine × Other neoplasm × Clear all
NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown
60 enrolled
Other neoplasm

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡